← Back to Search

SPI+ and CAMS for Suicide Prevention in Teens (ASSIST Trial)

N/A

Recruiting

Led By Molly Adrian

Research Sponsored by Seattle Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Admitted to acute care (emergency, inpatient medical or inpatient psychiatric) due to suicidality

Youth aged 11-17

Timeline

Screening 3 weeks

Treatment Varies

Follow Up suicide attempts at 12 months

Awards & highlights

ASSIST Trial Summary

This trial will test promising treatments for adolescent suicide risk and develop interventions that can be widely adopted.

Who is the study for?

This trial is for young people aged 11-17 who are experiencing suicidal thoughts or behaviors and have been admitted to acute care for these reasons. They must be able to give informed consent and understand English well enough for study assessments. It's not open to those with psychosis, intellectual disabilities, autism spectrum disorder, or unstable eating disorders.Check my eligibility

What is being tested?

The trial is testing two specific interventions against the usual treatment: Safety Planning Intervention+ (SPI+) and Collaborative Assessment and Management of Suicidality (CAMS). The goal is to see which method better helps teens during high-risk periods when they're dealing with suicidal thoughts or actions.See study design

What are the potential side effects?

Since this trial involves psychological interventions rather than medications, side effects may include emotional distress due to discussing sensitive topics like suicide. However, the exact nature of any potential side effects will depend on individual experiences.

ASSIST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was admitted to the hospital for feeling suicidal.

Select...

I am between 11 and 17 years old.

ASSIST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ suicidal events at 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~suicidal events at 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and suicidal events at 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Suicidal events

Secondary outcome measures

Suicidal Ideation

Suicide attempts

ASSIST Trial Design

3Treatment groups

Active Control

Group I: Treatment As Usual (TAU)Active Control1 Intervention

Participants in this group will be studied as they proceed through treatment in the acute care setting and follow the intervention plan laid out in the discharge summary, per usual protocols at each facility. In both settings, the elements of typical care include crisis prevention planning, which outlines potential triggers, skills to use, and people and places to call in crisis, as well as referral to ongoing behavioral health treatment. We will not alter usual care but track recommendations, contacts and care through questionnaires the family completes as well as medical record review in order to understand the impact of the experimental conditions in relation to typical services.

Group II: Collaborative Assessment and Management of Suicidality (CAMS)Active Control1 Intervention

CAMS strategies focus on collaborative deconstruction and treatment of the patient-defined drivers- the problems that make suicide compelling to the patient- and utilizes these problem-focused treatment sessions to treat the drivers as directly related to wish to die. Participants will be assigned to CAMS for a minimum of 4 sessions and a maximum of eight sessions. This time frame, based on initial data from our pilot work with adolescents and emerging adults (18-25), suggests that a subset of participants resolve their STB in six to eight sessions. CAMS is a clinical intervention designed to modify how clinicians engage, assess and plan treatment with suicidal patients.

Group III: Safety Planning Intervention+ (SPI+)Active Control1 Intervention

SPI is focused on how the risk of suicidal crisis waxes and wanes over time. At times of heightened risk, a pre-specified and individualized plan targets the internal warning signs that become the cue to use the safety plan. SPI+ strategies focus on patient's narrative of the suicidal crisis and identifying solutions that are antithetical to progressing in a suicidal crisis. The brief structured intervention is conducted in six key steps. Youth in this condition will be offered weekly follow-up, with a minimum of 4 sessions and a maximum of 8 sessions. The goal is to create a crisis response plan to reduce risk when suicidal crises emerge. With adolescents, SPI+ consists of an individual session to elicit crisis narrative and motivation to utilize the safety plan through psychoeducation and follows six steps to achieve the adolescent's goals and return to safety when suicidal urges are high.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Seattle Children's HospitalLead Sponsor

302 Previous Clinical Trials

5,216,418 Total Patients Enrolled

Nationwide Children's HospitalOTHER

341 Previous Clinical Trials

5,220,200 Total Patients Enrolled

Molly AdrianPrincipal InvestigatorSeattle Childrens

Media Library

Collaborative Assessment and Management of Suicidality (CAMS) Clinical Trial Eligibility Overview. Trial Name: NCT05078970 — N/A

Suicide and Self-Harm Research Study Groups: Treatment As Usual (TAU), Collaborative Assessment and Management of Suicidality (CAMS), Safety Planning Intervention+ (SPI+)

Suicide and Self-Harm Clinical Trial 2023: Collaborative Assessment and Management of Suicidality (CAMS) Highlights & Side Effects. Trial Name: NCT05078970 — N/A

Collaborative Assessment and Management of Suicidality (CAMS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05078970 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is geriatric participation welcome in this experiment?

"The age range for people who can participate in this research is between 11 to 17 years old."

Answered by AI

Who is eligible to participate in this medical trial?

"This research is enrolling 306 patients aged 11 -17 who have exhibited suicidal ideation or behaviour. Before they can take part, the participants must provide a signed and dated informed consent form, be admitted to acute care due to their suicidality, and meet all other requirements as outlined in the trial protocol."

Answered by AI

Is there still an opportunity for trial participants to join this experiment?

"According to the information posted on clinicaltrials.gov, this scientific trial is actively looking for research participants. It was initially published on August 11th 2022 and has since been modified as of that same date."

Answered by AI

How many subjects are involved in this research project?

"Affirmative. As per the information found on clinicaltrials.gov, this experiment is actively enrolling individuals into its trials and was first posted on August 11th 2022; with a most recent update occurring at the same time. The study requires 306 participants from two separate sites to complete it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

Molly Adrian 2022. "Advancing Suicide Intervention Strategies for Teens During High Risk Periods". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05078970.